Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Ovarian Cancer × sargramostim × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 43 Leukemia 41 Melanoma 40 Breast Neoplasms 32 Lymphoma, Follicular 30 Neuroblastoma 26 Lymphoma, Non-Hodgkin 24 Leukemia, Myeloid, Acute 24 Multiple Myeloma 23 Leukemia, Lymphocytic, Chronic, B-Cell 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Lymphoma, Large B-Cell, Diffuse 21 Prostatic Neoplasms 19 Lymphoma, Mantle-Cell 19 Lymphoma, Large-Cell, Immunoblastic 17 Carcinoma, Non-Small-Cell Lung 17 Ovarian Neoplasms 16 Lung Neoplasms 16 Glioblastoma 16 Myelodysplastic Syndromes 15 Neoplasms, Plasma Cell 14 Neoplasm Metastasis 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Burkitt Lymphoma 14 Leukemia, Myeloid, Chronic-Phase 13 Lymphoma, B-Cell, Marginal Zone 12 Hodgkin Disease 12 Gliosarcoma 12 Neoplasms 11 Carcinoma, Ovarian Epithelial 11

Interventions

Saline Solution 3 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡